Effect of dietary, pharmacological, and genetic topoisomerase ablation on Ph-like ALL risk in Hispanics

NIH RePORTER · NIH · R37 · $59,674 · view on reporter.nih.gov ↗

Abstract

The instructions from FOA PA-21-071 indicate that “At a minimum, the Research Strategy section should be completed and must include a summary or abstract of the parent award or project. Other sections should also be included if they are being changed by the proposed supplement activities.” The Project Summary/Abstract will not be changed as a result of the activities associated with this supplement.

Key facts

NIH application ID
10598405
Project number
3R37CA266042-01S1
Recipient
UNIVERSITY OF CALIFORNIA-IRVINE
Principal Investigator
Nicholas Pannunzio
Activity code
R37
Funding institute
NIH
Fiscal year
2022
Award amount
$59,674
Award type
3
Project period
2022-02-14 → 2027-01-31